Plain-English translation of NCT07509333 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Lung Neoplasms research guide →This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing a new way to care for older adults diagnosed with lung cancer. Instead of one doctor making treatment decisions alone, a coordinated team of specialists works together to create a personalized treatment plan based on each patient's age-related health needs, overall fitness, and cancer stage. The goal is to help older patients receive the right treatment at the right time, whether that's surgery, radiation, chemotherapy, immunotherapy, targeted therapy, or supportive care.
Older adults now make up most lung cancer cases, but they often aren't included in treatment research. This treatment approach is different because it recognizes that older patients have unique health challenges—like multiple medical conditions and physical changes—that require careful, individualized planning. This trial aims to prove that team-based, age-aware care can lead to better results.
You likely qualify if…
You likely don't qualify if…
You will first undergo baseline medical tests and assessments, including imaging scans, lung function tests, and comprehensive health evaluations. Then, a team of specialists (including surgeons, geriatricians, oncologists, rehabilitation experts, and radiologists) will meet to discuss your case and develop a personalized treatment plan based on your age, overall health, and cancer stage. After that, you'll receive your recommended treatment—which might be surgery, radiation, chemotherapy, immunotherapy, targeted therapy, or a combination—and attend regular follow-up visits to monitor your progress and complete questionnaires about how you're doing.
AI-generated summary from trial data · Sep 19, 2026 · Not medical advice
China